Citigroup Inc Bionano Genomics, Inc. Transaction History

Citigroup Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$0.57 - $1.16 $14,225 - $28,950	24,957 Added 25.32%	123,522 $75,000
Q1 2023 May 11, 2023	SELL	$1.06 - $1.97 $8,283 - $15,395	-7,815 Reduced 7.35%	98,565 $109,000
Q4 2022 Feb 09, 2023	SELL	$1.4 - $25.4 $120,558 - $2.19 Million	-86,113 Reduced 44.74%	106,380 $155,000
Q3 2022 Nov 10, 2022	SELL	$0.36 - $36.0 $24,381 - $2.44 Million	-67,726 Reduced 26.03%	192,493 $352,000
Q2 2022 Aug 10, 2022	SELL	$12.3 - $27.3 $1.16 Million - $2.58 Million	-94,470 Reduced 26.63%	260,219 $359,000
Q1 2022 May 12, 2022	SELL	$16.6 - $32.3 $1.14 Million - $2.22 Million	-68,844 Reduced 16.25%	354,689 $915,000
Q4 2021 Feb 10, 2022	BUY	$29.9 - $61.2 $1.06 Million - $2.17 Million	35,403 Added 9.12%	423,533 $1.27 Million
Q3 2021 Nov 10, 2021	BUY	$51.4 - $68.2 $19.9 Million - $26.5 Million	388,130 New	388,130 $2.14 Million

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $133M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.